SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Dyadic International, Inc. (DYAI) News

Follow Dyadic International, Inc. (DYAI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol DYAI Asset equity Sector Markets 90 days 4 Last 0.2905 Updated Sep 25, 2026, 09:36 PM UTC Open live news feed Open DYAI chart & news
L Dyadic International Disclosed Failure to Satisfy a Continued Listing Rule or Standard On September 25, 2026, the company received two Nasdaq deficiency notices for failing to meet the $1.00 minimum bid price under Rule 5550(a)(2) and the $35 million Market Value of Listed Securities under Rule 5550(b)(2). NEWS | Sep 25, 2026, 09:36 PM UTC L Q3 Virtual Investor Summit Presentations Now Available On Demand Q3 Virtual Investor Summit Presentations Now Available On Demand EQUITY | Aug 31, 2026, 10:15 PM UTC L DYAI: Commercial-stage protein platform drives growth with new products, partners, and recurring revenues DYAI: Commercial-stage protein platform drives growth with new products, partners, and recurring revenues EQUITY | Aug 26, 2026, 08:36 PM UTC L DYAI: Commercialization and recurring revenue accelerate as partnerships and product launches expand DYAI: Commercialization and recurring revenue accelerate as partnerships and product launches expand EQUITY | Aug 26, 2026, 08:11 PM UTC L Dyadic International secures $2.9 million in offering Dyadic International, Inc. says it secured $2.9 million through a registered direct offering and concurrent private placement. MNA | Aug 13, 2026, 12:02 PM UTC L DYAI Announces Q2 2026 Financial Results DYAI announces second quarter 2026 financial results EARNINGS | Aug 12, 2026, 12:30 PM UTC M Dyadic Expands Non-Animal Dairy Pipeline Dyadic signs new development agreement EQUITY | Aug 04, 2026, 11:25 AM UTC L DYAI - Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 DYAI - Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 EARNINGS | Aug 03, 2026, 08:30 PM UTC L DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bun DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bundibugyo ebolavirus antigens to FBS and Scripps for preclinical evaluation EQUITY | Jul 28, 2026, 12:31 PM UTC L DYAI Dyadic international - expands Bio-industrial pipeline with new proprietary industrial enzyme program - To pursue commercialization thr DYAI Dyadic international - expands Bio-industrial pipeline with new proprietary industrial enzyme program - To pursue commercialization through sales, collaborations, manufacturing, and licensing EQUITY | Jul 16, 2026, 12:01 PM UTC